Aspect’s platform technology constitutes an entirely new way of 3D bioprinting, engineered specifically with the capacity to fabricate physiologically complex living tissue on demand for broad applications in the life sciences. We have developed a sophisticated Lab-on-a-printer™ technology that enables unprecedented control over biomaterial composition and structure during tissue fabrication. As a consequence, we are able to develop advanced 3D tissue models much faster and using a wide spectrum of different cells, biomaterials, and growth factors. This enables the rapid printing of macro-scale 3D structures that incorporate intricate micro-level details to generate architecturally and functionally accurate human tissues. By enabling the user to program the structure, material composition and printing process in software, Aspect has enabled the production of a massive variety of potential living structures.